1. Home
  2. SPCB vs IPSC Comparison

SPCB vs IPSC Comparison

Compare SPCB & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$8.90

Market Cap

43.8M

Sector

Technology

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$0.62

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
IPSC
Founded
1988
2019
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
49.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SPCB
IPSC
Price
$8.90
$0.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$18.00
$3.00
AVG Volume (30 Days)
73.4K
840.4K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.84
N/A
Revenue
$26,739,000.00
$113,337,000.00
Revenue This Year
N/A
$1,590.09
Revenue Next Year
$27.13
N/A
P/E Ratio
$10.60
N/A
Revenue Growth
N/A
4122.69
52 Week Low
$3.14
$0.34
52 Week High
$18.95
$1.26

Technical Indicators

Market Signals
Indicator
SPCB
IPSC
Relative Strength Index (RSI) 43.64 64.47
Support Level $8.64 $0.54
Resistance Level $9.92 $0.62
Average True Range (ATR) 0.49 0.04
MACD 0.04 0.01
Stochastic Oscillator 28.62 95.74

Price Performance

Historical Comparison
SPCB
IPSC

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: